MedTrace Logo

Effect of Immune-enhancing Enteral Nutrition on Immunomodulation in Critically Ill Patients

NCT02569203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-10-06

No results posted yet for this study

Summary

To determine whether high-protein (24% of total calorie from protein) enteral nutrition of immune modulating nutrients (eg, ω-3 fatty acids and antioxidants) enriched with β-glucan stimulates immune functions compared with standard enteral nutrition (control: 20% of total calorie from protein) or high-protein (24% of total calorie from protein) enteral nutrition of immune modulating nutrients without β-glucan in critically ill patients.

Conditions

  • Critical Illness

Interventions

DIETARY_SUPPLEMENT

standard enteral nutrition

standard enteral nutrition

DIETARY_SUPPLEMENT

high-protein enteral nutrition of immune modulating nutrients enriched with β-glucan

high-protein enteral nutrition of immune modulating nutrients enriched with β-glucan

DIETARY_SUPPLEMENT

high-protein enteral nutrition of immune modulating nutrients without β-glucan

high-protein enteral nutrition of immune modulating nutrients without β-glucan

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Jong Ho Lee, Ph. D. · Dept. of Food and Nutrition, College of Human Ecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-749, South Korea

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569203 on ClinicalTrials.gov